High expression of RAD51D and XRCC2 was associated with poor prognosis in gastric cancer patients according to survival analysis conducted on the Kaplan–Meier Plotter website (http://kmplot.com/analysis/) (Figure 4H,I). Here, XRCC2 is linked to gastric cancer.